z-logo
open-access-imgOpen Access
Prognostic Values of C-Reactive Protein Levels on Clinical Outcome After Implantation of Sirolimus-Eluting Stents in Patients on Hemodialysis
Author(s) -
Hideki Ishii,
Takanobu Toriyama,
Toru Aoyama,
Hiroshi Takahashi,
Tetsuya Amano,
Mutsuharu Hayashi,
Miho Tanaka,
Yoshihiro Kawamura,
Yoshinari Yasuda,
Yukio Yuzawa,
Shoichi Maruyama,
Seiichi Matsuo,
Tatsuaki Matsubara,
Toyoaki Murohara
Publication year - 2009
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.109.889915
Subject(s) - medicine , conventional pci , percutaneous coronary intervention , cardiology , restenosis , hemodialysis , myocardial infarction , drug eluting stent , sirolimus , stent , revascularization
Percutaneous coronary intervention (PCI) using drug-eluting stents significantly reduces the risk of restenosis in the general population. However, in patients on hemodialysis, adverse cardiac events are frequently seen even if treated with drug-eluting stents. Recent studies suggest that C-reactive protein (CRP) reflects vascular wall inflammation and can predict adverse cardiac events. We evaluated possible prognostic values of CRP on outcomes in patients on hemodialysis undergoing PCI with drug-eluting stents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom